[{"NetIncomeLoss_1_Q2_USD":-26459000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":1.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q2_pure":0.99,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":238000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":74160000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_1_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.009,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q2_pure":0.009,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-549000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":983450.0,"DeferredIncomeCurrent_0_Q2_USD":977000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":464000.0,"AssetsCurrent_0_Q2_USD":309768000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":7570000.0,"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q2_USD":7570000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":195000.0,"LeaseAndRentalExpense_2_Q2_USD":300000.0,"LeaseAndRentalExpense_1_Q2_USD":100000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":480000.0,"CommonStockSharesIssued_0_Q2_shares":35148110.0,"FinancialInstrumentsOwnedAtFairValue_0_Q2_USD":286752000.0,"LandSubjectToGroundLeases_0_Q2_sqm":1577.0,"Assets_0_Q2_USD":318685000.0,"ShareBasedCompensation_2_Q2_USD":5811000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":3048000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":667931.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.24,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":5429419.0,"CommitmentsAndContingencies_0_Q2_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":35119952.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":35103294.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":370000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":25881000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":14238000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":13.7,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":3666000.0,"ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet_2_Q2_USD":1300000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":50000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":300000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":60000.0,"GrantsReceivableCurrent_0_Q2_USD":4232000.0,"CommonStockValue_0_Q2_USD":35000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_2_Q2_USD":-650000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":862000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-39993000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-26459000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-40372000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-26533000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":8265000.0,"OtherAssetsNoncurrent_0_Q2_USD":412000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":302933000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":2501000.0,"Liabilities_0_Q2_USD":29187000.0,"OperatingLeaseLiability_0_Q2_USD":3056000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":5.46,"DepreciationAndAmortization_2_Q2_USD":276000.0,"DepreciationAndAmortization_1_Q2_USD":200000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":22147000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":15101000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":862000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-3431000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":610000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":2810000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-39993000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-26459000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3227000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-379000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-74000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-33045000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":592000.0,"LiabilitiesCurrent_0_Q2_USD":20763000.0,"AccountsPayableCurrent_0_Q2_USD":11661000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":303072000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2603000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.94,"RestrictedCashNoncurrent_0_Q2_USD":139000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q2_pure":0.94,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q2_USD":-74000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0482,"AdditionalPaidInCapital_0_Q2_USD":403116000.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":286752000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.0042,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q2_pure":0.0084,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":103352.0,"OperatingLeasePayments_2_Q2_USD":374000.0,"OperatingLeasePayments_1_Q2_USD":189000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":29794000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2021000.0,"NetIncomeLoss_2_Q2_USD":-39993000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":34000.0,"CommonStockSharesOutstanding_0_Q2_shares":35148110.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-33382000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-113891000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":421000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-81000.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"OperatingIncomeLoss_2_Q2_USD":-48028000.0,"OperatingIncomeLoss_1_Q2_USD":-29339000.0,"PaymentsToAcquireOtherProductiveAssets_2_Q2_USD":60000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":34.27,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":5.82,"LiabilitiesAndStockholdersEquity_0_Q2_USD":318685000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":5811000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3227000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":3075.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":4831000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":555000.0,"OperatingExpenses_2_Q2_USD":48028000.0,"OperatingExpenses_1_Q2_USD":29339000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":3316000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q2_USD":110000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.14,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.75,"ProfitLoss_2_Q2_USD":-39993000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":230000.0,"StockholdersEquity_0_Q2_USD":289498000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":489000.0,"DeferredIncomeNoncurrent_0_Q2_USD":5693000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":5429419.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":1469512.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":26.56,"AccruedProfessionalFeesCurrent_0_Q2_USD":25000.0,"Ticker":"ITOS","CIK":"1808865","name":"ITEOS THERAPEUTICS, INC.","OfficialName":"iTeos Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1111962533.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20210811"}]